EverBridge

Benefit global patients and bridge the world by medtech innovation.

Established in 2021, EverBridge Group is rooted in Asia, and serves global customers. we focus on on building a global medical technology platform to treat high-prevalence chronic diseases.

Learn more

Peripheral vascular
Neuroscience
Integrated oncology diagnosis and treatment

Peripheral vascular

EverBridge group builds up a multi-dimensional product lines in the peripheral vascular field, such as balloons, guidewires, catheters, stents, accessories, and RFA equipments. We coverd the wide range of peripheral vascular interventional therapy. Compared to traditional surgical treatments, peripheral vascular interventions bring effective treatment with advantages such as minimal trauma, significant efficacy, and faster recovery. Patients experience reduced risks and discomfort, making it a highly promising approach for clinical applications.

Product center

Neuroscience

Focusing on the clinical treatment needs of the central nervous system, we are committed to becoming a global leader in neuroscience technology through continuous innovation. EverBridge group provides end-to-end solutions for neurological diseases, from diagnosis and comprehensive treatment to postoperative rehabilitation. By leveraging auxiliary technologies such as artificial intelligence, imaging, and brain-computer interfaces, combined with treatment methods like neurointervention, surgical techniques, and robot-assisted surgery, we aim to achieve full-cycle management for patients with neurological conditions.

Product center

Integrated oncology diagnosis and treatment

The integrated oncology diagnosis and treatment solution covers all stages of cancer care, from screening and diagnosis to treatment and rehabilitation. With the advancement and application of big data, artificial intelligence, and new medical materials, this integrated approach will utilize these technologies to deeply analyze and mine vast amounts of case data. Centered on the entire cycle of oncology care, we will provide patients with comprehensive, integrated, continuous, and industry-leading diagnostic and therapeutic solutions. The goal is to enhance the effectiveness of cancer treatment, reduce medical costs, improve patient experience, and ultimately drive for patients' life extension.

Product center

01/03

R&D innovation

EverBridge group has established the "Advanced MedTech Research Institutes". We put medical technology innovation as our core competancy. Leveraging our 6 technology centers, the institute has achieved deep integration and optimal allocation of R&D resources, successfully builds up an effective way for creating value through "from 0 to 1" research and development.